Aug 26 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's ...

McKesson Corp. MCK said Monday it has agreed to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC , or Core Ventures, a business and administrative-services ...

An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. By Christina Jewett and Ellen Gabler The case ...

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay about $2.49 ...

Bloomberg News had reported last month that McKesson and rival drug distributors Cencora and Cardinal Health were vying to ...

Irving-based McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay ...

McKesson Corp. is in advanced talks to buy a controlling stake in Florida Cancer Specialists & Research Institute, a privately-held operator of oncology clinics, according to people familiar with ...

McKesson said Monday it signed a definitive agreement to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures LLC, or Core Ventures, for $2.5 billion in cash.

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Drug distributor McKesson may about $3.5 billion for Florida Cancer Specialists & Research Institute, according to a ...

San Francisco, CA-based McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: MCK sits at a Zacks Rank #3 (Hold), holds a Value ...